PL2222712T3 - Polisacharydowe pochodne kwasu liponowego, ich wytwarzanie, zastosowanie jako kosmetyki skórne i urządzenia medyczne - Google Patents

Polisacharydowe pochodne kwasu liponowego, ich wytwarzanie, zastosowanie jako kosmetyki skórne i urządzenia medyczne

Info

Publication number
PL2222712T3
PL2222712T3 PL08865553T PL08865553T PL2222712T3 PL 2222712 T3 PL2222712 T3 PL 2222712T3 PL 08865553 T PL08865553 T PL 08865553T PL 08865553 T PL08865553 T PL 08865553T PL 2222712 T3 PL2222712 T3 PL 2222712T3
Authority
PL
Poland
Prior art keywords
preparation
medical devices
lipoic acid
polysaccharide derivatives
skin cosmetics
Prior art date
Application number
PL08865553T
Other languages
English (en)
Inventor
Fabrizio Picotti
Marco Bosco
Luca Stucchi
Matteo Fabbian
Original Assignee
Sigea S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigea S.R.L. filed Critical Sigea S.R.L.
Publication of PL2222712T3 publication Critical patent/PL2222712T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL08865553T 2007-12-21 2008-12-11 Polisacharydowe pochodne kwasu liponowego, ich wytwarzanie, zastosowanie jako kosmetyki skórne i urządzenia medyczne PL2222712T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002416A ITMI20072416A1 (it) 2007-12-21 2007-12-21 Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
EP08865553.5A EP2222712B1 (en) 2007-12-21 2008-12-11 Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices

Publications (1)

Publication Number Publication Date
PL2222712T3 true PL2222712T3 (pl) 2017-08-31

Family

ID=40315645

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08865553T PL2222712T3 (pl) 2007-12-21 2008-12-11 Polisacharydowe pochodne kwasu liponowego, ich wytwarzanie, zastosowanie jako kosmetyki skórne i urządzenia medyczne

Country Status (10)

Country Link
US (1) US8324356B2 (pl)
EP (1) EP2222712B1 (pl)
JP (1) JP5661470B2 (pl)
CA (1) CA2710123C (pl)
ES (1) ES2620456T3 (pl)
IL (1) IL206443A (pl)
IT (1) ITMI20072416A1 (pl)
PL (1) PL2222712T3 (pl)
PT (1) PT2222712T (pl)
WO (1) WO2009080220A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008130590A2 (en) * 2007-04-19 2008-10-30 Surmodics, Inc. Biodegradable matrix materials
KR101100803B1 (ko) * 2009-04-24 2011-12-29 서울과학기술대학교 산학협력단 리포아마이드가 결합된 고분자화합물과 이의 제조방법
CN102212146B (zh) * 2009-07-23 2013-02-13 苏州大学 一种侧链用硫辛酸修饰的亲水性聚合物
KR101161640B1 (ko) 2009-08-25 2012-07-02 서울과학기술대학교 산학협력단 리포산이 결합된 화합물과 이의 제조방법
KR101346661B1 (ko) * 2010-11-15 2014-02-06 부경대학교 산학협력단 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물
IT1403886B1 (it) 2010-12-15 2013-11-08 Sigea Srl Uso di esteri lipoati di glicosamminoglicani in campo tricologico
ITTO20110428A1 (it) 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
MX369409B (es) 2013-06-28 2019-11-07 Galderma Sa Método para la fabricación de un producto perfilado de ácido hialurónico.
DE102013220061A1 (de) 2013-10-02 2015-04-02 Henkel Ag & Co. Kgaa Leistungsgesteigerte Haarbehandlungsmittel
CN104497171B (zh) * 2015-01-07 2017-05-10 博瑞生物医药（苏州）股份有限公司 基于透明质酸的两亲聚合物、其制备方法与应用
ITRM20150204A1 (it) * 2015-05-13 2016-11-13 Nanofaber S R L Microspugne di acido ialuronico e metodo per la preparazione delle stesse
WO2016184998A1 (fr) 2015-05-21 2016-11-24 Ophtalmis Monaco Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur
PL3297626T3 (pl) 2015-05-21 2021-12-13 Ophtalmis Kompozycja oftalmiczna zawierająca kwas liponowy i kwas hialuronowy
EP3833695A1 (en) * 2018-08-07 2021-06-16 Merz Pharma GmbH & Co. KGaA Method for dynamic filtration of a cross-linked hydrogel
IT201900017387A1 (it) 2019-09-27 2021-03-27 Bmg Pharma S P A Idrogelo a base di zinco gluconato ed esteri dell’acido ialuronico
IT201900019724A1 (it) 2019-10-24 2021-04-24 Bmg Pharma S P A “procedimento in solvente organico per la purificazione dell’acido ialuronico sale sodico”
IT202000016984A1 (it) 2020-07-13 2022-01-13 Bmg Pharma S P A Composizioni igienizzanti e antiinfettive per le mucose orali
CN114276563B (zh) * 2020-12-14 2023-02-24 南京工业大学 医用水凝胶的制备方法、水凝胶及敷料
CN113072716A (zh) * 2021-03-17 2021-07-06 武汉理工大学 一种光交联壳聚糖水凝胶的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2589226A (en) * 1946-11-22 1952-03-18 Us Agriculture Acylation of polysaccharides in formamide
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US6288106B1 (en) * 1999-05-25 2001-09-11 Chronorx, Llc Processes for the synthesis and use of various α-lipoic acid complexes
IT1318403B1 (it) * 2000-03-17 2003-08-25 Cooperativa Ct Ricerche Poly T Esteri polisaccaridici di n-derivati di acido glutammico.
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
DE602006010852D1 (de) * 2005-05-18 2010-01-14 Eurand Pharmaceuticals Ltd Proliferationshemmendes arzneimittel
ITPD20050168A1 (it) 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
KR100740071B1 (ko) 2006-03-10 2007-07-16 한불화장품주식회사 리포익산 유도체 및 이를 함유한 피부외용제 조성물
JP2010520333A (ja) * 2007-03-01 2010-06-10 セダーズ−シナイ メディカル センター 〔１，２〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用

Also Published As

Publication number Publication date
CA2710123A1 (en) 2009-07-02
ES2620456T3 (es) 2017-06-28
EP2222712A1 (en) 2010-09-01
US20100255097A1 (en) 2010-10-07
EP2222712B1 (en) 2017-03-01
WO2009080220A1 (en) 2009-07-02
PT2222712T (pt) 2017-03-31
JP2011506701A (ja) 2011-03-03
IL206443A0 (en) 2010-12-30
US8324356B2 (en) 2012-12-04
CA2710123C (en) 2016-12-06
ITMI20072416A1 (it) 2009-06-22
JP5661470B2 (ja) 2015-01-28
IL206443A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
IL206443A0 (en) Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices
EP2494953A4 (en) EXTERNAL SKIN COSMETIC PREPARATION AND MEDICAL INSTRUMENT
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL213019A (en) Derivatives 1-Azo-3-Terroyl-Azoline, Pharmaceutical Preparations Containing and Using Them
EP2262469A4 (en) SKIN CARE COMPOSITIONS AND METHODS OF USE
IL207195A0 (en) Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
HK1187345A1 (en) Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
IL199945A (en) Hydrochloric acid derivatives, pharmaceuticals containing them and their use in the preparation of drugs
HK1243630A1 (zh) 1-甲基-n-(2，6-二甲苯基)-2-哌啶甲酰胺的皮膚用藥物組合物及其使用方法
EP2238969A4 (en) PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN AND COSMETIC PREPARATION
HK1139426A1 (en) Aqueous gel, external preparation for skin, and cosmetic preparation
ZA201003764B (en) Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
HK1176936A1 (en) Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
IL212567A (en) Zaxanthin, alone or in combination with rutin, spermidine, or both, for the treatment of scalp disorders, use of zaxanthin, alone or in combination with rutin, spermidine or both, for the preparation of a medicinal or cosmetic or nutritional preparation for the treatment of scalp, and a medicinal, cosmetic or nutritional preparation containing Alone or in a mixture with routine, spermidine, or both
ZA201103516B (en) Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
HK1158632A1 (en) Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same 2--1--2-
HK1167157A1 (en) Oil gelling agent, oil gelling composition containing said oil gelling agent, and external preparation or cosmetic for skin containing said oil gelling composition
ZA201004643B (en) Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
IL217519A (en) Derivatives of tazarotene, pharmaceutical preparations containing them and their use in the preparation of medicines for the treatment of skin diseases
GB201002301D0 (en) Coloring materail and its uses in particular in the field of cosmetics, especially for making up the skin and superficial body growths
ZA201004644B (en) "derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides,preparation thereof and therapeutic application thereof"
PL2106401T3 (pl) Pochodne pirolopirydyno-2-karboksyamidów, ich wytwarzanie i ich zastosowanie w lecznictwie
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
ZA201207173B (en) Substitution derivatives of n6-benzyladenosine-5'-monophosphate,methods of preparation thereof,use thereof as medicaments,and therapeutic preparation containing these compounds
ZA201004646B (en) Derivatives of n-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof